Last reviewed · How we verify
NCT05082207
Ischemic Preconditioning and Thiol-disulfide Balance
NA trial testing Remote Ischemic Preconditioning in Tourniquets in 60 participants. Completed in 15 May 2022.
17 April 2022
Quick facts
| Lead sponsor | Konya Meram State Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 16 October 2021 |
| Primary completion | 17 April 2022 |
| Estimated completion | 15 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Remote Ischemic Preconditioning
- sham group
Conditions studied
- Tourniquets — all drugs for Tourniquets →
Sponsor
Konya Meram State Hospital
Who can join
Adults 18 to 90, any sex, with Tourniquets. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Various strategies have been proposed to prevent or mitigate the effects of ischemia-reperfusion injury following the use of tourniquets in orthopedic surgery cases. One of them is applying "remote ischemic preconditioning." This randomized controlled trial is planned to evaluate the effectiveness of remote ischemic preconditioning in preventing tourniquet-induced ischemia-reperfusion injury in total knee arthroscopy with dynamic thiol-disulfide homeostasis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05082207
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Remote Ischemic Preconditioning
Trials testing the same drug.
- NCT06977230 — Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG · NA · recruiting
- NCT05147831 — Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Unde · NA · recruiting
- NCT03853473 — Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning · NA · completed
- NCT03273751 — The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy · NA · completed
- NCT04174261 — Ticagrelor in Remote Ischemic Preconditioning Study · Phase 4 · completed
Other recruiting trials for Tourniquets
Currently open trials in the same condition.
- NCT07412925 — Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR · NA · recruiting
Other Konya Meram State Hospital trials
Trials by the same sponsor.
- NCT07458360 — FRONT Block for Quality of Recovery After Total Hip Arthroplasty · NA · not yet recruiting
- NCT05296187 — Efficacy of TEAS On Prevention of Propofol Injection Pain in Children · NA · completed
- NCT06940167 — Comparison of Kinesio Taping and Myofascial Release in Cervicogenic Headache · NA · completed
- NCT06349005 — Laryngoscopy and Coronary Artery Bypass Graft Surgery · NA · completed
- NCT06210126 — Pectointercostal Fascial Plane Block Chronic Pain Sternotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05082207 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Konya Meram State Hospital
- Last refreshed: 17 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05082207.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing